VBI Vaccines - 24 Year Stock Price History | VBIV

Historical daily share price chart and data for VBI Vaccines since 1995 adjusted for splits. The latest closing stock price for VBI Vaccines as of September 19, 2019 is 0.49.
  • The all-time high VBI Vaccines stock closing price was 91.68 on August 02, 2005.
  • The VBI Vaccines 52-week high stock price is 2.78, which is 467.3% above the current share price.
  • The VBI Vaccines 52-week low stock price is 0.49, which is 0% below the current share price.
  • The average VBI Vaccines stock price for the last 52 weeks is 1.57.
VBI Vaccines Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 1.4638 1.6500 2.1200 0.4921 0.4921 -69.24%
2018 2.7983 4.4700 4.4700 1.2200 1.6000 -62.53%
2017 4.2770 3.2600 6.4600 3.1500 4.2700 37.74%
2016 3.8547 4.6200 5.0998 2.1000 3.1000 -36.48%
2015 5.4265 6.5540 6.5540 4.5400 4.8800 -26.73%
2014 7.8698 10.1000 12.7000 4.0400 6.6600 -34.06%
2013 9.5674 8.2000 17.9000 6.1000 10.1000 26.25%
2012 8.9909 6.0000 13.5000 5.6000 8.0000 50.94%
2011 10.1249 10.2000 13.0000 5.1000 5.3000 -51.38%
2010 13.1983 15.0000 16.2000 8.8000 10.9000 -31.45%
2009 13.5273 10.8000 25.1000 8.0000 15.9000 52.88%
2008 36.6861 48.7000 55.2000 10.0000 10.4000 -78.33%
2007 50.8385 50.6000 60.5000 43.5000 48.0000 -7.69%
2006 62.3355 60.0000 86.1000 47.8000 52.0000 -13.12%
2005 53.0885 41.5050 91.6800 38.2500 59.8500 44.22%
2004 40.1064 50.0000 76.5000 26.1000 41.5000 -9.49%
2003 28.4022 23.2500 52.3500 20.1000 45.8500 97.20%
2002 30.5246 35.5000 41.1500 23.0550 23.2500 -31.11%
2001 26.0372 25.7800 33.7500 20.6250 33.7500 30.92%
2000 34.6685 26.2500 45.0000 25.3000 25.7800 -4.16%
1999 21.8001 13.1250 27.5000 13.1250 26.9000 38.84%
1998 19.0222 25.6250 33.7500 10.0000 19.3750 -26.19%
1997 19.6668 13.7500 33.1250 12.8150 26.2500 90.91%
1996 10.4947 5.0000 17.5000 4.3750 13.7500 175.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.066B $0.003B
VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.966B 13.32
Gilead Sciences (GILD) United States $83.231B 10.22
CSL (CSLLY) Australia $72.709B 0.00
Celgene (CELG) United States $69.932B 10.82
Vertex Pharmaceuticals (VRTX) United States $44.858B 48.48
Illumina (ILMN) United States $44.542B 52.33
Biogen (BIIB) United States $43.376B 7.71
Regeneron Pharmaceuticals (REGN) United States $31.308B 14.21
Actelion (ALIOF) Switzerland $29.891B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.091B 12.17
SINO PHARMACEUT (SBMFF) China $17.812B 0.00
Incyte (INCY) United States $16.891B 49.71
Exact Sciences (EXAS) United States $13.653B 0.00
BioMarin Pharmaceutical (BMRN) United States $13.549B 0.00
Genmab (GNMSF) Denmark $12.505B 70.14
Seattle Genetics (SGEN) United States $11.778B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.952B 53.35
Alnylam Pharmaceuticals (ALNY) United States $9.507B 0.00
Galapagos (GLPG) Belgium $8.668B 0.00
QIAGEN (QGEN) Netherlands $7.676B 25.22
Bio-Techne Corp (TECH) United States $7.518B 51.94
Guardant Health (GH) United States $6.852B 0.00
Sarepta Therapeutics (SRPT) United States $6.220B 0.00
BeiGene (BGNE) Cayman Islands $6.215B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.092B 0.00
Amarin (AMRN) Ireland $6.048B 0.00
Bluebird Bio (BLUE) United States $5.938B 0.00
Moderna (MRNA) United States $5.871B 0.00
Exelixis (EXEL) United States $5.837B 15.17
Horizon Pharma Public (HZNP) Ireland $4.924B 12.52
ARGENX SE-ADR (ARGX) Netherlands $4.890B 0.00
Ascendis Pharma (ASND) Denmark $4.355B 0.00
Repligen (RGEN) United States $4.228B 82.04
China Biologic Products (CBPO) China $4.060B 25.34
Spark Therapeutics (ONCE) United States $4.007B 0.00
Blueprint Medicines (BPMC) United States $3.904B 0.00
Medicines (MDCO) United States $3.756B 0.00
MorphoSys AG (MOR) Germany $3.690B 0.00
Mirati Therapeutics (MRTX) United States $3.606B 0.00
Alkermes (ALKS) Ireland $3.375B 0.00
Immunomedics (IMMU) United States $3.246B 0.00
Emergent Biosolutions (EBS) United States $2.749B 41.29
Reata Pharmaceuticals (RETA) United States $2.714B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.700B 0.00
Genomic Health (GHDX) United States $2.652B 49.73
Arena Pharmaceuticals (ARNA) United States $2.605B 5.60
MyoKardia (MYOK) United States $2.566B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.512B 0.00
Amicus Therapeutics (FOLD) United States $2.434B 0.00
Halozyme Therapeutics (HALO) United States $2.402B 0.00
Acceleron Pharma (XLRN) United States $2.279B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.264B 0.00
NeoGenomics (NEO) United States $2.255B 120.61
Myriad Genetics (MYGN) United States $2.053B 21.55
Akcea Therapeutics (AKCA) United States $2.041B 0.00
Cambrex (CBM) United States $2.007B 25.37
Zai Lab (ZLAB) China $1.998B 0.00
Ligand Pharmaceuticals (LGND) United States $1.887B 23.86
Denali Therapeutics (DNLI) United States $1.763B 0.00
UniQure (QURE) Netherlands $1.737B 0.00
Insmed (INSM) United States $1.730B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.658B 0.00
Alder BioPharmaceuticals (ALDR) United States $1.565B 0.00
Coherus BioSciences (CHRS) United States $1.435B 0.00
REGENXBIO (RGNX) United States $1.421B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.399B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.335B 0.00
Alector (ALEC) United States $1.324B 0.00
Editas Medicine (EDIT) United States $1.252B 0.00
Sangamo Therapeutics (SGMO) United States $1.246B 0.00
RA PHARMCTL INC (RARX) United States $1.212B 0.00
AnaptysBio (ANAB) United States $1.154B 0.00
Fate Therapeutics (FATE) United States $1.151B 0.00
Innoviva (INVA) United States $1.126B 3.25
Athenex (ATNX) United States $1.093B 0.00
Epizyme (EPZM) United States $1.069B 0.00
Zymeworks (ZYME) Canada $1.014B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.980B 0.00
Twist Bioscience (TWST) United States $0.971B 0.00
Cara Therapeutics (CARA) United States $0.929B 0.00
ANI Pharmaceuticals (ANIP) United States $0.884B 14.77
WAVE Life Sciences (WVE) Singapore $0.879B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.875B 0.00
Codexis (CDXS) United States $0.860B 0.00
Principia Biopharma (PRNB) United States $0.838B 436.88
Arvinas (ARVN) United States $0.820B 0.00
Pharming Group (PHGUF) Netherlands $0.793B 0.00
Zealand Pharma (ZEAL) Denmark $0.766B 8.88
Cytokineticsorporated (CYTK) United States $0.766B 0.00
UROGEN PHARMA (URGN) United States $0.757B 0.00
Anika Therapeutics (ANIK) United States $0.749B 26.50
ZIOPHARM Oncology Inc (ZIOP) United States $0.744B 0.00
Intellia Therapeutics (NTLA) United States $0.727B 0.00
Zealand Pharma (ZLDPF) Denmark $0.723B 0.00
Vericel (VCEL) United States $0.712B 0.00
Mesoblast (MESO) Australia $0.708B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.703B 25.36
Revance Therapeutics (RVNC) United States $0.617B 0.00
MiMedx (MDXG) United States $0.584B 0.00
DBV Technologies S.A (DBVT) France $0.579B 0.00
Heska (HSKA) United States $0.546B 70.74
Achillion Pharmaceuticals (ACHN) United States $0.532B 0.00
Retrophin (RTRX) United States $0.530B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.526B 0.00
Cellectis S.A (CLLS) France $0.521B 0.00
Stemline Therapeutics (STML) United States $0.508B 0.00
Intra-Cellular Therapies (ITCI) United States $0.504B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.502B 0.00
Precision BioSciences (DTIL) United States $0.494B 0.00
PHARMA MAR SA (PHMMF) Spain $0.468B 0.00
Syros Pharmaceuticals (SYRS) United States $0.466B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.440B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
BioDelivery Sciences (BDSI) United States $0.429B 0.00
Arcus Biosciences (RCUS) United States $0.424B 0.00
CytomX Therapeutics (CTMX) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.409B 0.00
Agenus (AGEN) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.404B 0.00
Adverum Biotechnologies (ADVM) United States $0.399B 0.00
Merus (MRUS) Netherlands $0.398B 0.00
Bellus Health (BLU) Canada $0.391B 0.00
Protagonist Therapeutics (PTGX) United States $0.364B 0.00
AC Immune SA (ACIU) Switzerland $0.351B 26.00
Gritstone Oncology (GRTS) United States $0.350B 0.00
Kadmon Holdings (KDMN) United States $0.344B 0.00
Prothena (PRTA) Ireland $0.342B 0.00
Scholar Rock Holding (SRRK) United States $0.330B 0.00
Theratechnologies (THERF) Canada $0.327B 0.00
Avid Bioservices (CDMO) United States $0.326B 0.00
Albireo Pharma (ALBO) United States $0.316B 0.00
ADMA Biologics Inc (ADMA) United States $0.314B 0.00
Biofrontera AG (BFRA) Germany $0.312B 466.67
Kindred Biosciences (KIN) United States $0.309B 0.00
Sorrento Therapeutics (SRNE) United States $0.309B 0.00
Pfenex (PFNX) United States $0.307B 0.00
Cel-Sci (CVM) United States $0.301B 0.00
Starpharma Holdings (SPHRY) Australia $0.295B 0.00
Dynavax Technologies (DVAX) United States $0.289B 0.00
Cellular Biomedicine (CBMG) United States $0.288B 0.00
Clovis Oncology (CLVS) United States $0.281B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.276B 0.00
Geron (GERN) United States $0.271B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
Senesco Technologies (ELOX) United States $0.259B 0.00
MannKind (MNKD) United States $0.254B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.250B 0.00
ChromaDex (CDXC) United States $0.250B 0.00
Sutro Biopharma (STRO) United States $0.249B 0.00
PDL BioPharma (PDLI) United States $0.249B 6.41
Inovio Pharmaceuticals (INO) United States $0.249B 0.00
Prometic Life Sciences (PFSCF) Canada $0.242B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.240B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.238B 0.00
Affimed (AFMD) Germany $0.228B 0.00
POXEL SA FRANCE (PXXLF) France $0.228B 0.00
Athersys (ATHX) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.224B 0.00
Compugen (CGEN) Israel $0.220B 0.00
EXICURE INC (XCUR) United States $0.217B 0.00
Palatin Technologies (PTN) United States $0.215B 6.32
Bicycle Therapeutics (BCYC) United Kingdom $0.213B 0.00
Kamada (KMDA) Israel $0.207B 7.92
CorMedix Inc (CRMD) United States $0.203B 0.00
Cue Biopharma (CUE) United States $0.199B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.197B 0.00
Five Prime Therapeutics (FPRX) United States $0.196B 0.00
XOMA (XOMA) United States $0.188B 0.00
OSMOTICA PHARM (OSMT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.183B 0.00
Arsanis (XFOR) United States $0.175B 0.00
Nicox SA (NICXF) France $0.173B 0.00
Acorda Therapeutics (ACOR) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.168B 0.00
Alcobra (ARCT) United States $0.166B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Dyadic (DYAI) United States $0.164B 0.00
Novavax (NVAX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.159B 0.00
Abeona Therapeutics (ABEO) United States $0.158B 0.00
Strongbridge Biopharma (SBBP) United States $0.150B 6.16
BioTime (LCTX) United States $0.150B 10.00
Northwest Biotherapeutics (NWBO) United States $0.145B 0.00
Cerecor (CERC) United States $0.143B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.143B 0.00
PHASEBIO PHARMA (PHAS) United States $0.142B 0.00
Adocia (ADOCY) France $0.140B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.135B 0.00
Aptinyx (APTX) United States $0.134B 0.00
NantKwest (NK) United States $0.134B 0.00
Emmaus Life Sciences (EMMA) United States $0.133B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Fortress Biotech (FBIO) United States $0.125B 0.00
Menlo Therapeutics (MNLO) United States $0.122B 0.00
SESEN BIO, INC (SESN) United States $0.111B 0.00
Celyad SA (CYAD) Belgium $0.101B 0.00
Aduro Biotech (ADRO) United States $0.100B 0.00
Verastem (VSTM) United States $0.096B 0.00
OvaScience (MLND) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.093B 0.00
Trevena (TRVN) United States $0.093B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.092B 0.00
Arbutus Biopharma (ABUS) Canada $0.091B 0.00
Vaccinex (VCNX) United States $0.090B 0.00
Checkpoint Therapeutics (CKPT) United States $0.090B 0.00
Mersana Therapeutics (MRSN) United States $0.087B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.086B 0.00
Idera Pharmaceuticals (IDRA) United States $0.084B 0.00
Selecta Biosciences (SELB) United States $0.080B 0.00
Antibe Therapeutics (ATBPF) Canada $0.079B 0.00
ARAVIVE, INC (ARAV) United States $0.078B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Liquidia Technologies (LQDA) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.073B 0.00
Catalyst Biosciences (CBIO) United States $0.073B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.072B 0.00
Curis (CRIS) United States $0.070B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Orgenesis (ORGS) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
Pluristem Therapeutics (PSTI) Israel $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.064B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.062B 0.00
Unum Therapeutics (UMRX) United States $0.061B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.059B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
AIT Therapeutics (XAIR) United States $0.050B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Proteostasis Therapeutics (PTI) United States $0.048B 0.00
Stellar Biotechnologies (EDSA) Canada $0.046B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Oncobiologics (OTLK) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
VIVUS (VVUS) United States $0.045B 0.00
Evogene (EVGN) Israel $0.042B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
BIOCARDIA INC (BCDA) United States $0.039B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
Organovo Holdings (ONVO) United States $0.036B 0.00
DiaMedica Therapeutics (DMAC) United States $0.033B 0.00
Protalix BioTherapeutics (PLX) Israel $0.032B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Alimera Sciences (ALIM) United States $0.030B 0.00
Entera Bio (ENTX) Israel $0.029B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.029B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Fibrocell Science Inc (FCSC) United States $0.028B 9.73
Apricus Biosciences (SEEL) United States $0.027B 0.00
Clearside Biomedical (CLSD) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aytu Bioscience (AYTU) United States $0.024B 0.00
TOCAGEN INC (TOCA) United States $0.020B 0.00
Novelion Therapeutics (NVLN) Canada $0.020B 0.00
Novogen (KZIA) Australia $0.019B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
CollPlant Holdings (CLGN) Israel $0.015B 0.00
IBio (IBIO) United States $0.015B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
TrovaGene (TROV) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Advaxis (ADXS) United States $0.006B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (CUR) United States $0.004B 0.00